MLICM
BHVN icon

Metropolitan Life Insurance Company (MetLife)’s Biohaven BHVN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,605
Closed -$197K – 283
2024
Q1 		$197K Sell
3,605
-302
-8% -$15K 0.01% 724
2023
Q4 		$167K Buy
3,907
+514
+15% +$16K 0.01% 823
2023
Q3 		$88.3K Buy
3,393
+183
+6% +$3.8K ﹤0.01% 1084
2023
Q2 		$76.8K Buy
+3,210
New +$55.3K ﹤0.01% 1163
2023
Q1 		– Sell
-3,990
Closed -$55.4K – 2326
2022
Q4 		$55.4K Buy
+3,990
New +$56.3K ﹤0.01% 1412

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s BHVN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Biohaven (BHVN) in Q2 2024, closing a stake of 3,605 shares — an estimated $197K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BHVN in Q4 2022 and held it in 5 quarters. The position peaked at $197K in Q1 2024. 225 funds tracked by Wall St. Rank hold BHVN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Biohaven position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,605 Biohaven shares in Q2 2024, an estimated $197K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Biohaven in Q4 2022 and held it in 5 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Biohaven position peaked at $197K in Q1 2024.
  • 225 funds tracked by Wall St. Rank held Biohaven as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.